Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B8QA
|
||||
| Former ID |
DIB000141
|
||||
| Drug Name |
RP-66055
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cerebral infarction [ICD10:I63] | Terminated | [1] | ||
| Company |
Rhone-Poulenc SA
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H22FN3S
|
||||
| Canonical SMILES |
c1(=N)n(c2c(s1)cc(OC(F)(F)F)cc2)CCN1CCN(c2ccc(cc2)F)CC1<br />.Cl.Cl
|
||||
| CAS Number |
CAS 133783-43-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [2] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003439) | ||||
| REF 2 | Synthesis, anticonvulsant and neuroprotective activities of RP 66055, a riluzole derivative. Bioorg Med Chem. 1994 Aug;2(8):793-8. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.